[1]
|
M. R. Prausnitz and R. Langer, “Transdermal Drug De-livery,” Nature Biotechnology, Vol. 26, No. 11, 2008, pp. 1261-1268. doi:10.1038/nbt.1504
|
[2]
|
M. R. Prausnitz, S. Mitragotri and R. Langer, “Current Status and Future Potential of Transdermal Drug Delivery,” Nature Reviews Drug Discovery, Vol. 3, No. 2, 2004, pp. 115-124. doi:10.1038/nrd1304
|
[3]
|
M. B. Brown, et al., “Dermal and Transdermal Drug Delivery Systems: Current and Future Prospects,” Drug Delivery, Vol. 13, No. 3, 2006, pp. 175-187.
doi:10.1080/10717540500455975
|
[4]
|
A. Samad, et al., “Transdermal Drug Delivery System: Patent Reviews,” Recent Patents on Drug Delivery & Formulation, Vol. 3, No. 2, 2009, pp. 143-152.
doi:10.2174/187221109788452294
|
[5]
|
R. K. Subedi, et al., “Recent Advances in Transdermal Drug Delivery,” Archives of Pharmacal Research, Vol. 33, No. 3, 2010, pp. 339-351.
doi:10.1007/s12272-010-0301-7
|
[6]
|
A. K. Banga, “Microporation Applications for Enhancing Drug Delivery,” Expert Opinion on Drug Delivery, Vol. 6, No. 4, 2009, pp. 343-354.
doi:10.1517/17425240902841935
|
[7]
|
T. R. Singh, et al., “Microporation Techniques for Enhanced Delivery of Therapeutic Agents,” Recent Patents on Drug Delivery & Formulation, Vol. 4, No. 1, 2010, pp. 1-17. doi:10.2174/187221110789957174
|
[8]
|
V. Sachdeva and A. K. Banga, “Microneedles and Their Applications,” Recent Patents on Drug Delivery & Formulation, Vol. 5, No. 2, 2011, pp. 95-132.
doi:10.2174/187221111795471445
|
[9]
|
J. Birchall, et al., “Cutaneous Gene Expression of Plasmid DNA in Excised Human Skin Following Delivery via Microchannels Created by Radio Frequency Ablation,” International Jour-nal of Pharmaceutics, Vol. 312, No. 1-2, 2006, pp. 15-23.
doi:10.1016/j.ijpharm.2005.12.036
|
[10]
|
N. H. Zech, M. Murtinger and P. Uher, “Pregnancy after Ovarian Superovulation by Transdermal Delivery of Follicle-Stimulating Hormone,” Fertility and Sterility, Vol. 95, No. 8, 2011, pp. 2784-2785.
doi: 10.1016/j.fertnstert.2011.03.073
|
[11]
|
A. V. Badkar, et al., “Transdermal Delivery of Interferon Alpha-2B Using Microporation and Iontophoresis in Hairless Rats,” Pharmaceutical Research, Vol. 24, No. 7, 2007, pp. 1389-1395. doi:10.1007/s11095-007-9308-2
|
[12]
|
H. Kalluri and A. K. Banga, “Transdermal Delivery of Proteins,” AAPS PharmSciTech, Vol. 12, No. 1, 2011, pp. 431-441. doi:10.1208/s12249-011-9601-6
|
[13]
|
F. J. McGovern, et al., “Radio Frequency Ablation of Renal Cell Carcinoma via Image Guided Needle Electrodes,” Journal of Urology, Vol. 161, No. 2, 1999, pp. 599-600. doi:10.1016/S0022-5347(01)61961-X
|
[14]
|
S. N. Gold-berg, “Radiofrequency Tumor Ablation: Principles and Techniques,” European Journal of Ultrasound, Vol. 13, No. 2, 2001, pp. 129-147.
doi:10.1016/S0929-8266(01)00126-4
|
[15]
|
J. H. Park, et al., “The effect of heat on skin permeability,” International Journal of Pharmaceutics, Vol. 359, No. 1-2, 2008, pp. 94-103.
doi:10.1016/j.ijpharm.2008.03.032
|
[16]
|
A. C. Sintov, et al., “Radiofrequency-Driven Skin Microchanneling as a New Way for Electrically Assisted Transdermal Delivery of Hydrophilic Drugs,” Journal of Controlled Release, Vol. 89, No. 2, 2003, pp. 311-320.
doi:10.1016/S0168-3659(03)00123-8
|
[17]
|
G. Levin, et al., “Transdermal Delivery of Human Growth Hormone through RF-Microchannels,” Pharmaceutical Research, Vol. 22, No. 4, 2005, pp. 550-555.
doi:10.1007/s11095-005-2498-6
|
[18]
|
K. Okimoto, R. A. Rajewski and V. J. Stella, “Release of Testosterone from an Osmotic Pump Tablet Utilizing (SBE)7m-Beta-cyclodextrin as Both a Solubilizing and an Osmotic Pump Agent,” Journal of Controlled Release, Vol. 58, No. 1, 1999, pp. 29-38.
doi:10.1016/S0168-3659(98)00142-4
|
[19]
|
J. Pitha, S. M. Harman and M. E. Michel, “Hydrophilic Cyclodextrin Derivatives Enable Effective Oral Administration of Steroidal Hormones,” Journal of Pharmaceutical Sciences, Vol. 75, No. 2, 1986, pp. 165-167.
doi:10.1002/jps.2600750213
|
[20]
|
T. Loftsson, et al., “Effects of Cyclodextrins on Drug Delivery through Biological Membranes,” Journal of Pharmaceutical Sciences, Vol. 96, No. 10, 2007, pp. 2532-2546. doi:10.1002/jps.20992
|
[21]
|
M. E. Brewster and T. Loftsson, “Cyclodextrins as Pharmaceutical Solubilizers,” Advanced Drug Delivery Reviews, Vol. 59, No. 7, 2007, pp. 645-666.
doi:10.1016/j.addr.2007.05.012
|
[22]
|
H. Kalluri and A. K. Banga, “Formation and Closure of Microchannels in Skin Following Microporation,” Pharmaceutical Research, Vol. 28, No. 1, 2011, pp. 82-94.
doi: 10.1007/s11095-010-0122-x
|
[23]
|
I. Lavon and J. Kost, “Ultrasound and Transdermal Drug Delivery,” Drug Discovery Today, Vol. 9, No. 15, 2004, pp. 670-676. doi:10.1016/S1359-6446(04)03170-8
|
[24]
|
B. E. Polat, D. Blankschtein and R. Langer, “Low-Frequency Sonophoresis: Application to the Transdermal Delivery of Macromolecules and Hydrophilic Drugs,” Expert Opinion on Drug Delivery, Vol. 7, No. 12, 2010, pp. 1415-1432. doi:10.1517/17425247.2010.538679
|
[25]
|
K. V. Roskos and R. H. Guy, “Assessment of Skin Barrier Function Using Transepidermal Water Loss: Effect of Age,” Pharmaceutical Research, Vol. 6, No. 11, 1989, pp. 949-953. doi:10.1023/A:1015941412620
|
[26]
|
G. Grubauer, P. M. Elias and K. R. Feingold, “Transepider-mal Water Loss: The Signal for Recovery of Barrier Structure and Function,” Journal of Lipid Research, Vol. 30, No. 3, 1989, pp. 323-333.
|
[27]
|
A. Anigbogu, et al., “An in Vivo Investigation of the Rabbit Skin Responses to Transdermal Iontophoresis,” International Journal of Pharmaceutics, Vol. 200, No. 2, 2000, pp. 195-206. doi:10.1016/S0378-5173(00)00371-9
|
[28]
|
F. W. Benech-Kieffer and H. Schaefer, “Transepidermal Water Loss as an Integrity Test for Skin Barrier Function in Vitro: Assay Standardization,” In: K. R. Brain, V. J. James and K. A. Walters, Eds., Perspectives in Percutaneous Penetration, STS Publishing, Cardiff, 1977, p. 56.
|
[29]
|
FDA Wound Healing Clinical Focus Group, “Guidance for Industry: Chronic Cutaneous Ulcer and Burn Wounds- Developing Products for Treatment,” Wound Repair and Regeneration, Vol. 9, No. 4, 2001, pp. 258-268.
doi:10.1046/j.1524-475X.2001.00258.x
|
[30]
|
R. Panchagnula, K. Stemmer and W. A. Ritschel, “Animal Models for Transdermal Drug Delivery,” Methods & Findings in Experimental & Clinical Pharmacology, Vol. 19, No. 5, 1997, pp. 335-341.
|
[31]
|
R. F. Diegelmann and M. C. Evans, “Wound Healing: An Overview of Acute, Fibrotic and Delayed Healing,” Frontiers in Bioscience, Vol. 9, 2004, pp. 283-289.
doi:10.2741/1184
|
[32]
|
D. Montandon, G. D’Andiran and G. Gabbiani, “The Mechanism of Wound Contraction and Epithelialization: Clinical and Experimental Studies,” Clinics in Plastic Surgery, Vol. 4, No. 3, 1977, pp. 325-346.
|
[33]
|
J. Gupta, et al., “Kinetics of Skin Resealing after Insertion of Microneedles in Human Subjects,” Journal of Controlled Release, Vol. 154, No. 2, 2011, pp. 148-155.
doi:10.1016/j.jconrel.2011.05.021
|